Apalutamide

Overview

Apalutamide is a nonsteroidal antiandrogen used in the treatment of prostate cancer. It works by inhibiting the action of androgens (male hormones) that can promote tumor growth.

API suppliers (1)

Suppliers of Apalutamide backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Porton Pharma Solutions Ltd.China

Patent & exclusivity (US)

Per the FDA Orange Book (3 approved US products), the latest listed US patent on Apalutamide expires 14 Jan 2041. Generic API sourcing typically opens up once these lapse.

Therapeutic areas